Additional file 1: of Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity
Tomoko Ikeda(Tohoku University), Hideo Harigae(Tohoku University Hospital), Hiroshi Fujii(Nara Women's University), Tsuyoshi Shirai(Tohoku University), Yuko Shirota(Tohoku University), Yukiko Kamogawa(Tohoku University), Masato Nose(Meiji University), Tomonori Ishii(Tohoku University)
Cited by 0
Related Papers
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
|Immunity|1999|2.7k
Covalency-reinforced oxygen evolution reaction catalyst
|Nature Communications|2015|542
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
|The Journal of Experimental Medicine|2016|534
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523